相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
Adrian von Witzleben et al.
CELLS (2020)
Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma
San Jiun Chai et al.
DISEASE MARKERS (2019)
Immunogenic neoantigens derived from gene fusions stimulate T cell responses
Wei Yang et al.
NATURE MEDICINE (2019)
In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients
San Jiun Chai et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
Rainer C. Miksch et al.
CANCERS (2019)
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
Zhiyong Wang et al.
NATURE COMMUNICATIONS (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
Alex Allen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Targeting Head and Neck Cancer by Vaccination
Chuan Wang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments
Jong W. Yu et al.
PLOS ONE (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer
Anusha-Preethi Ganesan et al.
NATURE IMMUNOLOGY (2017)
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
Katy J. McCann et al.
CLINICAL CANCER RESEARCH (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors
Oliver Wood et al.
ONCOTARGET (2016)
Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma
Scott V. Bratman et al.
JAMA ONCOLOGY (2016)
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
Encouse B. Golden et al.
LANCET ONCOLOGY (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
Yoshihiro Yoshitake et al.
CLINICAL CANCER RESEARCH (2015)
Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma
San Jiun Chai et al.
PLOS ONE (2015)
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
M. J. Ward et al.
BRITISH JOURNAL OF CANCER (2014)
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer
Simon Laban et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
Viktor H. Koelzer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy
Kue Peng Lim et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
Lindsey Chudley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and is associated with poor disease outcome
Chan Eng Chong et al.
CANCER LETTERS (2012)
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
Helene Pere et al.
BLOOD (2011)
Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
Akihiro Miyazaki et al.
CANCER SCIENCE (2011)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma
D. Joseph-Pietras et al.
LEUKEMIA (2010)
Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival
Saman Warnakulasuriya
ORAL ONCOLOGY (2010)
Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals
Sebastian Kreiter et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Immunization with mutant p53- and K-ras-derived peptides in cancer patients:: Immune response and clinical outcome
DP Carbone et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
DNA vaccines to attack cancer
FK Stevenson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Comparative analysis of the CD8+ T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice
H Firat et al.
INTERNATIONAL IMMUNOLOGY (2002)
DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: Implications for cancer vaccines
J Rice et al.
JOURNAL OF IMMUNOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
